Low-Dose Naltrexone in Gastroenterology: A Bonafide ‘Wonder Drug’

Low-Dose Naltrexone in Gastroenterology: A Bonafide ‘Wonder Drug’ By: Leonard Weinstock, M.D. – 3rd May 2024 https://www.gidoctor.net/gastroenterology-blog/low-dose-naltrexone-in-gastroenterology From flatulence and belches to sporadic and potentially embarrassing bowel movements, gastroenterologists hear it all. We understand the frustration of all symptoms attributed to the gastrointestinal tract, and it is indeed why we set out to specialize in […]

Crohn’s disease: Nottingham man spends seven years “exhausted” by bowel disease. (News)

27th Nov 2023 https://www.nationalworld.com/health/crohns-disease-nottingham-man-exhausted-4423997 John Tarr, 59, has spent the better part of a decade living with Crohn’s disease, which causes debilitating bowel problems. Symptoms of Crohn’s can include pain, diarrhoea, tiredness and blood in your poo – but other parts of the body can also be affected. For the past 10 months, John has […]

Is Fibromyalgia a Fashionable Diagnosis or a Medical Mystery? (Abstract)

Is Fibromyalgia a Fashionable Diagnosis or a Medical Mystery? Cureus 07 September 2023 https://pubmed.ncbi.nlm.nih.gov/37809234/ Despite its prevalence, there is no clear-cut diagnostic path or treatment paradigm for fibromyalgia; this can lead to a multiplicity of symptoms and comorbid conditions that complicate care. “Overlapping symptoms” describe conditions that can occur concomitantly with fibromyalgia and include migraine, […]

Low-dose naltrexone for the induction of remission in patients with mild to moderate Crohn’s disease… (Abstract)

Low-dose naltrexone for the induction of remission in patients with mild to moderate Crohn’s disease: protocol for the randomised, double-blinded, placebo-controlled, multicentre LDN Crohn study BMJ Open 08 April 2022 https://pubmed.ncbi.nlm.nih.gov/35396307/ Introduction: Crohn’s disease (CD) is an inflammatory bowel disease (IBD). Several drugs exist to induce and maintain remission, but a significant part of the […]